Firms

Saras Capital

Saras Capital is a London-based early-stage investment firm backing companies at the intersection of technology and biology. It invests in AI and software for the biopharmaceutical industry, computational therapeutics and AI-native biotechnology companies. Its second fund, Saras Capital II LP, reached a final close in January 2026. The firm is legally Saras Capital LLP and operates as an appointed representative of Midmar Capital LLP.

Founded: 2020
Type: Venture capital

Funds1

Saras Capital II LP2026-01-202026-01-20—
Second Saras Capital fund, with a successful final close announced in January 2026. Invests in early-stage vertical AI and SaaS for the biopharma industry and AI-native biotechnology companies. Isomer Capital is a disclosed fund investor. The announcement does not disclose the fund’s total size.